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Abstract
Background: The analysis of humoral responses directed against the saliva of blood-sucking arthropods was shown to
provide epidemiological biomarkers of human exposure to vector-borne diseases. However, the use of whole saliva as
antigen presents several limitations such as problems of mass production, reproducibility and specificity. The aim of this
study was to design a specific biomarker of exposure to tsetse flies based on the in silico analysis of three Glossina salivary
proteins (Ada, Ag5 and Tsgf1) previously shown to be specifically recognized by plasma from exposed individuals.
Methodology/Principal Findings: Synthetic peptides were designed by combining several linear epitope prediction
methods and Blast analysis. The most specific peptides were then tested by indirect ELISA on a bank of 160 plasma samples
from tsetse infested areas and tsetse free areas. Anti-Tsgf118–43 specific IgG levels were low in all three control populations
(from rural Africa, urban Africa and Europe) and were significantly higher (p,0.0001) in the two populations exposed to
tsetse flies (Guinean HAT foci, and South West Burkina Faso). A positive correlation was also found between Anti-Tsgf118–43
IgG levels and the risk of being infected by Trypanosoma brucei gambiense in the sleeping sickness foci of Guinea.
Conclusion/Significance: The Tsgf118–43 peptide is a suitable and promising candidate to develop a standardize
immunoassay allowing large scale monitoring of human exposure to tsetse flies in West Africa. This could provide a new
surveillance indicator for tsetse control interventions by HAT control programs.
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Introduction
With less than 10 000 reported cases in 2009 across Africa [1],
the goal of elimination of human African trypanosomiasis (HAT),
caused by Trypanosoma brucei gambiense (T. b. gambiense) and T. b.
rhodesiense and transmitted by tsetse flies, seems again to be in sight
[2]. Active surveillance by medical surveys, during which mass
screening of the population is made to identify and treat infected
persons in order to reduce the human reservoir, were shown to be
effective and resulted in a 69% reduction in the number of new
case during the period 1997–2006 in T. b. gambiense endemic areas.
Out of the 36 endemic countries, 20 are now close to achieving the
target of reporting no new cases and eight reported ,100 new
cases per year [3]. Nevertheless it is also known that this strategy
becomes less effective when disease prevalence is becoming low,
both because of the weariness from endemic populations leading
to dramatic decrease in medical survey attendance [4], and
because of cost related issues as the cost to diagnose a patient
becomes prohibitive. In the absence of a vaccine or prophylactic
molecules for mass treatment, vector control thus appears as an
important complementary strategy to reach the goal of elimination
or at least a sustainable control of HAT [5]. With the Pan African
Tsetse and Trypanosomiasis Eradication Campaign (PATTEC),
large scale tsetse eradication campaigns are now underway in
several African countries such as in Uganda and Ethiopia in East
Africa and Ghana, Burkina Faso and Senegal in West Africa in
order to improve the breeding and agricultural potential of these
animal African trypanosomiasis (AAT) endemic areas [6]. Vector
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control campaigns are now progressively extending to HAT
endemic areas in combination with medical surveys such as in the
Boffa focus along the Guinean coast [7].
Although a diversity of methods are now available to control
tsetse populations such as ground and aerial spraying of
insecticides, live-bait technologies, insecticide-treated targets/traps
and use of the sterile insect technique [8], a major challenge still
resides in the evaluation of their efficacy and the definition of
pertinent indicators to measure intervention successes. Currently
entomological evaluation is performed through the monitoring of
sentinel traps to measure the apparent tsetse flies density per trap
and per day and thus to determine the reduction ratio compared
to starting densities [9]. This entomological method nevertheless
presents a number of important limitations, namely low sensitiv-
ities or efficiencies, as it was shown that only 20% of the traps
attracted flies are actually captured [10,11]. In addition it has been
suggested that traps become less efficient when tsetse densities
decrease [12] possibly due to density-dependant dispersal [13].
They may thus lead to an underestimation of the true densities.
Furthermore, tsetse density itself only poorly reflects the intensity
of contact with human populations which is the most crucial
parameter when the objective of vector control is to reduce human
tsetse contacts to levels incompatible with maintenance of the
parasite life cycle [7,14,15].
The fact that exposed hosts develop an antibody response
against the saliva of blood sucking arthropods has provided a new
way to assess individual host exposure to a number of important
vectors such as mosquitoes [16–18], ticks [19,20], triatomines [21]
or sand flies [22]. Accordingly, we were able to show, in a recent
study, that individuals from tsetse infested areas displayed
significantly higher antibody titers against whole saliva extracts
from Glossina palpalis gambiensis (G. palpalis gambiensis), the main
vector of T. b. gambiense in West Africa, as compared to unexposed
individuals [23]. Nevertheless, the use of whole saliva extracts is
also associated with mass production associated issues that
preclude their use for large scale studies [24]. Furthermore, some
salivary antigens are conserved and common among the different
species of blood sucking arthropods, inducing cross-reactions and
loss of specificity when whole saliva extracts are used in
immunoassays [25]. To overpass these problems, salivary recom-
binant proteins have been used to develop standardized epidemi-
ological serological tools to assess exposure to ticks [26,27], sand
flies [28,29], triatomines [30] or to the afrotropical malaria vectors
[31]. Another approach, less demanding in terms of laboratory
facilities and well adapted to the environment of research
laboratories in Africa, has been to identify specific and immuno-
genic peptides from the salivary proteins sequences available in the
data banks. This strategy was successfully applied to develop
serological markers of human exposure to Aedes aegypti [32] and
Anopheles gambiae [33,34].
In this paper we describe an ‘‘in silico’’ approach, in which
several epitope prediction and protein conformation software’s
were used in combination with blast analyses to define synthetic
peptides to assess human exposure to tsetse flies in West Africa.
For this study we included three proteins sequences that were
shown to be specifically recognized by sera from individuals
exposed to tsetse flies [23]: adenosine deaminase (Ada); Antigen 5
(Ag5) and Tsetse Saliva Growth Factor1 (Tsgf1). Most antigenic
and specific predicted peptides were then synthesized and tested
against a bank of plasma samples collected in populations exposed
or not to tsetse flies.
Materials and Methods
Ethics statement
Human plasma samples were collected from tsetse infested areas
from Guinea and Burkina Faso and tsetse-free areas from Burkina
Faso (Bobo-Dioulasso), Southern Benin and France. All samples,
used in previously published studies [23,32,35], were collected
according to the ethical principles of the Helsinki Declaration and
were anonymized. All samples collected in Guinea and Burkina
Faso were collected during medical surveys led by the National
Control Programs of these two countries according to the
respective national HAT diagnostic procedures. All participants
were informed of the objectives of the study in their own language
and signed a written informed consent form. These samples are
part of a larger project aiming to improve HAT diagnosis for
which approval was obtained from the WHO Research Ethics
Review Committee (RPC222) and from the IRD ethical commit-
tee (December 2007). Samples from Benin were part of a study on
Aedes aegyti exposure [32] which was approved by the National
Ethical Committee of Benin (IRB 00006860) and the IRD ethical
committee (April 2008).
Human plasma
A total of 160 samples were included for the purpose of this
study as follows:
Guinean HAT foci. 80 plasma samples, collected during
medical surveys performed by the National Control Program of
Guinea (mean age= 35.4 years old [5–80]) in the Forecariah and
Dubreka mangrove HAT foci [23,35] that are currently the most
active foci in West Africa. The Guinean mangrove ecosystem
harbors high densities of G. palpalis gambiensis [7] and humans
living in these areas are in close contact with tsetse flies during
their daily activities [36]. Thirty six samples were from individuals
diagnosed as HAT patients, and 44 were from uninfected
individuals sampled in the same villages.
Batie´ (Burkina Faso). 10 samples collected from villagers
(mean age = 32 years old [7–78]) during a medical survey led by
the National Control Program of Burkina Faso in 2008. Batie´ is
located in South-West (SW) Burkina Faso in a HAT historical
focus where tsetse flies and animal trypanosomiasis are still present
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Increasing interest is paid to blood-sucking arthropod’s
salivary antigens to develop host direct biomarkers of
exposure. Nevertheless use of whole saliva is problematic
both because of mass production and specificity issues.
Here, we describe an in silico approach we used to identify
potential epitopes on the amino acid sequence of three
tsetse salivary proteins (Ada, Ag5 and Tsgf1) that were
previously shown to be specifically recognized by anti-
bodies from exposed individuals. Three candidate peptides
were synthesized and evaluated on a set of plasma
collected in different tsetse-infested and tsetse-free
areas. The Tsgf118–43 synthetic peptide appeared as a
promising candidate to assess human exposure to tsetse
flies as antibody responses were low in all three control
groups and were significantly higher in our two exposed
groups. Significantly higher anti- Tsgf118–43 responses
were also observed in sleeping sickness patients as
compared to uninfected controls suggesting that
Tsgf118–43 may be used both to assess human tsetse
contacts and the risk of infection by trypanosomes. This
new sero-epidemiological tool could thus help National
Control Programs to quickly map human exposure levels
in order to better target vector control efforts and
monitor vector control efficiency.
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[37]. In SW Burkina Faso, three major tsetse species can be
encountered. G. palpalis gambiensis and G. tachinoides are riverine
species found in forests galleries along rivers. G. morsitans
submorsitans is a savannah fly that is progressively disappearing
due to the reduction of the wild life fauna and to the degradation
of its habitat in relation with increasing human environmental
pressure, and is now largely restricted to protected areas [38]. No
HAT cases have been diagnosed in this area during a survey
during which 4531 individuals were screened [39].
Bobo-Dioulasso (Burkina Faso). 17 samples collected from
citizen volunteers (mean age = 24.8 years old [18–33]) that did not
report travelling outside of the city for at least three months [23].
Bobo-Dioulasso is the second city in Burkina Faso and is
considered free of tsetse flies. Inhabitants are nevertheless exposed
to a number of other biting arthropods such as Culex mosquito
species, Anopheles gambiae s.l., Anopheles arabiensis [40] or sandflies.
Tsetse flies are nevertheless present in sites that are in the
neighborhood of the city and we cannot exclude that some study
subjects may have experienced occasional exposure while visiting
these sites. Samples were included as our ‘‘urban African
unexposed group’’.
Southern Benin. 31 samples collected during a longitudinal
survey of a cohort of children aged between 1 and 5 years old
conducted between February 2008 and October 2009 in 7 villages
of the Kpomasse-Tori Bossito health district in southern Benin as
detailed elsewhere [32]. In this area of southern Benin where
riparian forests are highly degraded and only few sacred wood
persist due to the intense agricultural activities led in the area, the
presence of tsetse flies is very unlikely. Nevertheless, although
study samples were chosen in villages located away from river sites
and all were from young children, as in Bobo-Dioulasso we cannot
however exclude that some study subjects may have been
occasionally bitten by tsetse flies. Samples were included as our
‘‘rural African unexposed group’’.
Bordeaux (France). As a ‘‘non African unexposed group’’
we also included 22 samples collected from adult blood donors of
the French blood bank (Etablissement Franc¸ais du Sang) in
Bordeaux.
Peptide identification
Bioinformatics analyses were carried on the mature protein
sequences (signal peptide removed) of the Glossina Ada (D3TR66),
Tsgf1 (Q9U7C6), and Ag5 (D3TMF1) salivary proteins that were
previously shown to react specifically with plasma from tsetse
infested areas [23]. Protein sequences were from G. morsitans
morsitans as they are currently the only available tsetse sequences in
the data banks. In a first step, each of the protein sequences was
sequentially submitted to an array of four different epitope
prediction algorithms. The identification of putative linear B-cell
epitopes was performed on the NETSurfP [41], ABCpred [42]
and Bcepred [43] servers using the B cell epitope database
BCIPEP [44], which contains 3 031 entries that include 763
immunodominant, 1 797 immunogenic, and 471 null-immuno-
genic epitopes [45]. MHC class2 binding regions were also
searched with the Proped-2 online service [46]. All epitopes (5–6
amino-acid length) that were identified by at least three out of four
algorithms were selected for further analyses. In a second step, 10
amino acid sequences were added on each side of the selected
epitopes and corresponding sequences were blasted on all non-
redundant Genbank CDS databases [47]. After this step the best
candidate peptide (with highest specificity to Glossina) was selected
for each of the study salivary antigens (Ada, Ag5 and Tsgf1).
Accessibility of candidate peptides at the surface of the protein was
then checked by performing 3D structure models of the proteins
with Phyre [48] and verified with the molProbity server [49].
Peptides were synthesized by the Genepep Company (Saint-Jean
de Vedas, France) with a purity control by HPLC.94%. All
peptides were shipped lyophilized and were resuspended in ultra-
pure water and then frozen in aliquots.
Peptide immunoassays
ELISA (Enzyme Linked ImmunoSorbent Assay) was used to
measure the peptides specific IgG responses in human plasma.
Maxisorp plates (Nunc, Roskilde, Denmark) were coated for 2 h
30 min at 37uC with peptides (20 mg/ml) diluted in carbonate/
bicarbonate buffer. After washing with PBS tween 0.1%, plates
were saturated 1 h with the TBS-protein free Blocking Buffer
(Pierce, Rockford, IL, USA). Plasma diluted in PBS-Tween 1%
(1:10 for Ada188–213 and Ag5105–130, 1:40 for Tsgf118–43) were
incubated overnight at 4uC. Anti-human IgG biotinylated
antibodies (BD Pharmingen, San Diego, CA, USA) diluted 1/
1000 in PBS Tween 1% or in Blocking Buffer (for Ada188–213),
were incubated for 1 h at 37uC. This step was followed by 1 h
incubation with streptavidine coupled with peroxidase (1:1000)
(GE healthcare biosciences, Uppsala, Sweden). The colorimetric
development was done with ABTS (2,29-azino-bis (3-ethyl-
benzthiazoline 6-sulfonic acid), Sigma, St Louis, MO, USA)
diluted in 50 mM citrate buffer (pH 4) containing 0,003% of
H2O2. The optical density was measured at 405 nm. Each plasma
sample was tested in duplicate and once in a well without antigen.
The individual results were expressed in DOD measured
according to the following formula: DOD=ODx–ODn where
ODx is the average of the duplicate wells and ODn the optical
density of the well without Ag. When DOD values were negative
DOD were considered to be 0.
Statistical analysis
Statistical analyses were carried out with the GraphPad Prism
software (San Diego, CA, USA). After verifying that the values did
not assume a Gaussian distribution, the Mann Whitney U
nonparametric test was used to compare IgG levels between two
independent groups and the Kruskal-Wallis nonparametric test for
comparison between more than two groups. Differences were
considered significant for p,0.05.
Results
Peptide design
In a previous immune-proteomic approach combining 2-D
electrophoresis and mass spectrometry, we were able to identify
three proteins (Ada, Ag5 and Tsgf1), from G. palpalis gambiensis
saliva extracts, that reacted specifically with IgG from individuals
exposed to tsetse bites [23]. After the first screening step, where the
sequence of each protein was submitted to four different epitope
prediction algorithms, four to seven candidate epitopes (5 to 6 aa)
were identified by at least three of the prediction algorithms for
each of the study protein (Table 1). In a second step, candidate
eptitope sequences (the 5–6 aa sequence added of 10 aa on each
side) were submitted to Blast analysis with Genbank CDS non
redundant databases. For each candidate sequence we calculated
the difference between the Blast E-values for G. morsitans morsitans
and the closest match in order to assess the specificity of candidate
peptides to the Glossina genus (Table 1). For each protein, the
peptide displaying the greatest difference were: Ada188–213 (G.
morsitans morsitans, e = 3.10216; Drosophila melanogaster, e = 5.6);
Tsgf118–43 (G. morsitans morsitans, e = 4.10
215; Marinobacter algicola,
e = 1.3) and Ag5105–130 (G. morsitans morsitans, e = 2.10
216; Vibrio
mimicus, e = 7.8). No relevant similarity was found with known
A Synthetic Peptide to Assess Tsetse Exposure
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human pathogens. After checking for peptide accessibility at the
surface of the protein on 3-D models (Figure 1), Ada188–213,
Tsgf118–43 and Ag5105–130 were synthesized and tested on human
plasma samples.
Peptide validation on human plasma samples
In order to assess antigenicity, each of the candidate peptide was
evaluated in an ELISA immunoassay on a set of 13 plasma
samples collected in tsetse-infested areas (Guinea and South West
Burkina Faso) and displaying high IgG levels against G. palpalis
gambiensis whole saliva extracts [23]. The highest IgG responses
were observed for Tsgf118–43 (8/13 samples with DDO.0; median
of positive DDO=0.79) whereas IgG responses appeared much
weaker for Ada188–213 (8/13 samples with DDO.0; median of
positive DDO=0.03) or absent for Ag5105–130 (Figure 1). This last
peptide was thus abandoned in further analysis.
The result of the ELISA immunoassay performed with
Tsgf118–43 and Ada188–213 on our sample of plasma collected
from population exposed (Guinea, Batie´) or not (Bobo-
Dioulasso, South Benin and Bordeaux) to tsetse flies are shown
in Figure 2. For Ada188–213 IgG responses were again low but
were significantly higher in plasma from Guinea as compared to
those from Bobo-Dioulasso and Bordeaux (p = 0.03). The same
trend, although not significant, was observed for the sample
from Batie´ (p = 0.15). Nevertheless strong immune responses to
Table 1. Predicted antigenic peptides within the Glossina morsitans morsitans Ada, Tsgf1 and Ag5 salivary proteins.
Consensus peptides E-value G.m. morsitans Best match specie (E-value)
ADA
Seq171–96: 2.10
216 Burkholderia pseudomallei (0,96)
HLSTGGEVQLNSKEIEVDRIFMKYKI
Seq2110–135 6.10
217 Drosophila mojavensis (5.10213)
AAGMHFFKAKPLIERSKVFRFLQQMP
Seq3168–193 6.10
217 Leptospirillum ferrodiazotrophum (1,7)
DQRGINILTFRENPERHKCTTQYVAV
Seq4174–199 4.10
217 Drosophila mojavensis (0,0088)
ILTFRENPERHKCTTQYVAVNEERQK
Seq5188–213 3.10
216 Drosophila melanogaster (5,6)
TQYVAVNEERQKSRSQADYNRSFENL
Seq6292–317 1.10
215 Drosophila pseudoobscura pseudoobscura (4,2)
DVLTVILEVVGSFRSQYPDFLGVKLI
Seq7315–340 1.10
216 Arthrospira platensis str. Paraca (2,3)
KLIYAINRRLETNEVRNRVEILKKFQ
TSGF1
Seq11–20 1.10–10 Methylobacter tundripaludum (0,17)
EVNKAYQDERNKILQEEEKL
Seq218–43 4.10–15 Marinobacter algicola (1,3)
EKLRLGYDVILQGDEEKADQIFLRLK
Seq3130–156 3.10–16 Paramecium tetraurelia (0,4)
DGCKSESVQVSKGEAKEDWFNLYTPT
Seq4207–232 3.10–16 Candida tropicalis (0,71)
EVRVKFSEPYDDTSKKYSLDDVVKEI
Seq5436–461 9.10–15 Lactobacillus delbrueckii subsp. Bulgaricus (0,4)
VENTIKYAQLNSQEKTAETLLKAKWN
AG5
Seq114–39 2.10
214 Daphnia pulex (3)
VACVSQNVFQSGCSSDAKMIDLKKYQ
Sep2105–130 2.10
216 Vibrio mimicus (7,8)
NLAELGRSGAGTPDYGQLIQKAVDS
Seq3203–226 2.10
213 Drosophila melanogaster (1,7)
KSCSASAQDCKTGKNSKYQNLCSA
Seq4221–243 1.10
214 Stomoxys calcitrans (0,008)
QNLCSANEKYEVNRWFKDGVEYQ
All peptides that were identified by at least three out of four epitope prediction servers (NETSurfP, ABCpred, Bcepred and Proped-2) are listed for each protein. Within
peptide sequences, amino acids forming the linear epitope are bolded. Each peptide was then blasted on all non-redundant Genbank CDS databases. Blast E-value for
G. morsitans morsitans and the best match species are indicated. For each protein, the candidate peptide selected for biological validation is underlined.
doi:10.1371/journal.pntd.0002455.t001
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the Ada188–213 peptide were observed in almost all plasma samples
from South Benin (the rural African control group) and two from
Bobo-Dioulasso (the urban African control group) indicating
potential cross-reactions for this candidate peptide. For Tsgf118–43
a low level of IgG reactivity was observed in all tsetse-free areas
(median DOD=0.02 in Bobo-Dioulasso, and 0.00 in South Benin
and Bordeaux). In contrast Tsgf118–43 specific IgG levels were highly
significantly increased in both tsetse-infested sites (Guinea, median
DOD=0.1, p,0.0001; Batie, median DOD=0.08, p=0.0001).
Finally Tsgf118–43 was evaluated as a marker/indicator of the
HAT risk in the Guinean disease foci (Figure 3) by comparing
Tsgf118–43 specific antibodies levels between HAT patients (n = 36)
and T. b. gambiense uninfected controls (n = 44). HAT patients
displayed significantly higher anti-Tsgf118–43 specific antibody
responses as compared to uninfected individuals (median
DDO=0.15 and 0.05 respectively, p = 0.001).
Discussion
In a previous work, we identified three G. palpalis gambiensis
salivary antigens (Ada, Ag5 and Tsgf1) that were specifically
recognized by IgG antibodies from individuals exposed to tsetse
flies in West Africa [23]. Here we report on the performance, as
marker of exposure, of three synthetic peptides that were designed
from these protein sequences by a bioinformatics approach and
then tested on plasma from individuals naturally exposed or not to
tsetse flies. We show that one of them (Tsgf118–43) is a promising
candidate to assess tsetse human contact in HAT foci.
Out of the three candidate peptides selected by the in silico
approach, Ag5105–130 did not induce any response when tested
with plasma samples that were shown to strongly react with G.
palpalis gambiensis whole salivary antigens, and two appeared to be
antigenic although responses observed with Ada188–213 were much
weaker as compared to Tsgf118–43. This was somehow an expected
result, as the predictive value of the epitope prediction algorithms
that were used in this study are known to be in the range of only 50
to 65% [42,43]. Furthermore, for bioinformatics analyses we had
to rely on protein sequences from G. morsitans morsitans as no G.
palpalis gambiensis sequences are yet available. The low or absent
antigenicity observed for Ada and Ag5 respectively may thus
therefore result from sequence differences between G. morsitans
morsitans and G. palpalis gambiensis to which our study population are
exposed. Nevertheless, as the use of G. morsitans morsitans sequences
may be regarded as a limitation to our study design, an advantage
is also that the potential candidate peptide identified by our
approach may be used not only to monitor G. palpalis gambiensis
exposure in West Africa, but also exposure to G. morsitans morsitans
and possibly other tsetse species in East and Central Africa.
In the next step of the analysis, we evaluated the specificity of
the Tsgf118–43 and Ada188–213 candidate peptides to detect
exposure to tsetse flies by comparing specific IgG responses in
plasma samples collected from a variety of populations from tsetse
infested areas and tsetse free areas. Unexpectedly, all plasma
samples from South Benin and 2 samples from Bobo-Dioulasso
reacted strongly in the Ada188–213 ELISA immunoassay, evidenc-
ing that antibodies unrelated to tsetse exposure have the potential
to induce cross reactions with this synthetic peptide. This is in
contrast with the results of our Blast analysis that did not evidence
any close matches to this peptide sequence. It is however clear that
all sources of human antigens have not yet been sequenced and are
thus not present in the data bases that were used for our ‘‘in silico’’
approach. Nonetheless, Tsgf118–43 appeared to be a good
Figure 1. 3D models of the Ada, Tsgf1, and Ag5 Glossina salivary proteins. 3D structure models were realized with Phyre and verified with
molProbity server. The position of each selected candidate peptide is highlighted in red. Each peptide was evaluated in an ELISA indirect
immunoassay against 13 plasma samples previously shown to react strongly with Glossina palpalis gambiensis whole saliva extracts [23]. Results are
expressed in terms of number of plasma samples with DDO.0 and median and range of positive values for each synthetic peptide.
doi:10.1371/journal.pntd.0002455.g001
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Figure 2. Tsgf118–43 and Ada188–213 IgG responses in plasma samples from tsetse infested and tsetse free areas. IgG levels to Tsgf118–43
(A) and Ada188–213 (B) were assessed by indirect ELISA in different study population from tsetse infested areas (Guinea; n = 80 and Batie´; n = 10) and
tsetse free areas (Bobo-Dioulasso; n = 17; South Benin; n = 31, and Bordeaux; n = 22). Asterisks ‘‘*’’ above the dot plots indicate that some values were
higher than 0.65 for A (1.14, 1.21, 1.86, 3.10, 4.06 and 4.11) and higher than 1 for B (2.45). The horizontal bars in the graph represent the median of
DDO values for each group.
doi:10.1371/journal.pntd.0002455.g002
Figure 3. Anti-Tsgf118–43 IgG levels in HAT patients and uninfected controls. This analysis only includes the plasma samples collected in the
Guinean HAT foci. Thirty six samples were from parasitologically confirmed HAT patients and 44 were from uninfected controls from the same
villages. The Mann Whitney test was used to compare Tsgf118–43 specific IgG levels between the two groups. The horizontal bars in the graph
represent the median of DDO values for each group. Asterisks ‘‘*’’ above the dot plots indicate that some values were higher than 0.8 in the patient
group (4.11, 3.10, 1.85, 1.21, 1.14) and control group (4.06). The p-value of Mann Whitney U nonparametric test for the comparison between the two
groups is given above the plot.
doi:10.1371/journal.pntd.0002455.g003
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candidate to assess human exposure to tsetse flies. Anti-Tsgf118–43
IgG responses were low in all our control groups (from rural,
urban Africa and France) and were highly and significantly
elevated in plasma samples collected from our two populations
from tsetse-infested areas (Guinea and SW Burkina Faso).
Noteworthy an intermediate response was observed in one of
the study control from Bobo-Dioulasso suggesting that anti-
Tsgf118–43 antibodies may not be entirely specific of tsetse
exposure; we can however also not completely rule out that this
subject was truly exposed to tsetse bites in the near neighborhood
of the city. These results are similar to those previously reported
when using G. palpalis gambiensis whole saliva extracts [23].
Importantly however, a higher proportion of intermediate
responses was observed in individuals from tsetse-free areas when
whole saliva extracts were used, thus suggesting a better specificity
of Tsgf118–43 to assess human exposure to tsetse flies. Furthermore,
whereas no association had been observed between specific IgG
levels directed against whole saliva extracts and the risk of HAT
[23], anti-Tsgf118–43 antibodies were more elevated in HAT
patients as compared to uninfected individuals in the Guinean
HAT foci. Here a possible explanation to this result could be again
that examining plasma reactivity to a single epitope provides a
better specificity to assess tsetse exposure as compared to whole
saliva extracts. The saliva of blood sucking arthropod is composed
of a complex mixture of proteins, some of which are common and
conserved across species [50]. Use of whole salivary antigens may
thus lead to potential spurious reactions impairing immunoassays.
All together, these results suggest that anti-Tsgf118–43 IgG
antibodies could serve both as a direct biomarker of exposure to
tsetse bites in West Africa and also as a marker to assess the T. b.
gambiense infection risk in endemic areas. We were not able in the
framework of this study to assess the dynamics of apparition and
disappearance of Glossina saliva specific antibodies and the relation
between IgG responses and the individual tsetse exposure levels.
To this end, anti-Tsgf118–43 IgG antibodies will be evaluated in
sentinel villages from the Boffa focus in Guinea, before and after
tsetse control intervention have been taken [7]. Noteworthy, we
were able to show, that in cattle experimentally bitten by tsetse
flies, Glossina saliva specific antibodies returned to pre-exposure
levels within only few weeks after the stop of exposure (Somda et
al., personnal communication).
Defining immunoassays that enable to overpass issues associated
with the use of whole saliva extracts has been a major challenge to
develop specific and sensitive tools to detect/measure host
exposure to blood sucking arthropods. Resort to recombinant
proteins has proved to be an efficient way to develop standardized
immunoassays to a variety of disease vectors such as ticks, sanflies,
triatomines or to Afrotropical malaria vectors [27,28,30,31,51].
Nevertheless, the production and the storage/shipment of
recombinant proteins are often problematic and require good
facilities which limit their use in many contexts such as in
developing countries. On the contrary synthetic peptides are easy
to produce and can be stored lyophilized. In this paper we have
used an ‘‘in silico’’ approach to select candidate peptides within the
sequence of our candidate proteins as experimental methods used
for characterizing epitopes are time consuming and demand large
resources. A similar approach has previously been successfully
applied to design the gSG6-P1 peptide [33,34,52] from the gSG6
protein, a small anopheline-specific salivary protein [31]. In our
study, out of only three synthetic peptides selected by bioinformatics
tools, one was a good candidate characterized by a good antigenicity
and specificity confirming further the validity of this approach. For
logistic reasons we were only able to test three synthetic peptides,
but other peptides identified within the Ada, Tsgf1 and Ag5
sequences (Table 1), with similar Blast estimated specificity to the
Glossina genus, would now be interesting to test. Other salivary
proteins could also be included as, although cross-reactive antibody
may exist against the whole protein [23], some epitopes could be
specific of the Glossina genus. Indeed whereas, as stated above,
Tsgf118–43 appears as a good candidate to assess exposure to tsetse
flies providing a good specificity of the immunoassay, relying on
only one epitope may impair sensitivity to detect anti-tsetse saliva
antibodies as this specific epitope may not be recognized by all
individuals exposed to tsetse bites. Indeed, in a recent study in which
sera of mice experimentally bitten by Phlebotomus papatasi were tested
against four different salivary recombinant proteins, it was shown
that whereas each mice serum reacted with at least one of the
recombinant protein, none of the recombinant proteins were
recognized by all sera [53]. In a similar way it was shown that a
combination of two Lutzomia longipalpis recombinant salivary
antigens performed better than each of the individual ones to
predict human anti-salivary gland sonicate positivity [28].
In this paper, we have shown that the analysis of plasma
reactivity to the Tsgf118–43 synthetic peptide provides an easy and
cheap way to monitor human exposure to tsetse flies in West
Africa and in contrast to whole saliva extracts to assess HAT risk in
endemic populations. Combining such a serological test with the
mass screening Card Agglutination Test for Trypanosomiasis [54],
performed on thousands of individuals during medical surveys,
could provide National Control Programs with important
indicators to quickly map human exposure levels in order to
better target vector control efforts and to monitor the efficiency of
vector control campaigns to lower human tsetse contacts. Finally,
we have confirmed that in silico approaches represent interesting
and useful tools to design synthetic peptide to assess human
exposure to arthropod bites. Inclusion of other Glossina salivary
antigens and biological validation of other predicted antigenic
peptides identified in the framework of this study should thus
enable to improve further the sensitivity of anti-Glossina saliva
specific IgG detection by allowing the design of peptide cocktail
based immunoassay.
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